Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Quality of Life Treatment Efficacy Remission Rates Risk Stratification Mortality Rates Drug Efficacy Efficacy and Safety Gender Differences Treatment Response

4 ARTICLES

4w ago

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

NHS England has struck a deal with MSD to fund immediate access through the Cancer Drugs Fund and expects about 550 patients to be eligible over two years.

5 ARTICLES

last mo.

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

7 ARTICLES

last mo.

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

4 ARTICLES

last mo.

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

3 ARTICLES

2mo ago

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

6 ARTICLES

2mo ago

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

3 ARTICLES

2mo ago

MD Anderson Maps Triple-Negative Breast Cancer at Single-Cell Resolution and Unveils 13-Gene Model to Predict Chemo Response

6 ARTICLES

2mo ago

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

5 ARTICLES

2mo ago

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

4 ARTICLES

2mo ago

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

4 ARTICLES

4mo ago

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

3 ARTICLES

6mo ago

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

4 ARTICLES

6mo ago

First Pivotal Trial Finds Cooled-Laser Prostate Therapy Effective at 3 Months With Low Morbidity

4 ARTICLES

6mo ago

First NHS Patient Completes Next‑Generation CAR‑T Therapy for Aggressive Leukaemia

Patient Outcomes

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

Dapagliflozin Cuts Heart-Failure Hospitalizations by About 80% in People With Cardiomyopathy Genes

New Oral Drug Nearly Doubles Survival for Treated Metastatic Pancreatic Cancer

Experimental ERAP1 Inhibitor Plus Immunotherapy Shrinks Tumours in Early Trial

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

MD Anderson Maps Triple-Negative Breast Cancer at Single-Cell Resolution and Unveils 13-Gene Model to Predict Chemo Response

Personalized DNA Vaccine Shows Strong Immune Response in Early Glioblastoma Study

Meta-Analysis Backs Low-Dose Digitalis for Heart Failure With Fewer Worsening Events

FDA Approves Bizengri for NRG1 Fusion-Positive Cholangiocarcinoma

Never miss stories about

Patient Outcomes

Study Details VeloCD Blood Method to Predict Illness Trajectory

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

FDA Approves First Gene Therapy for Inherited Hearing Loss

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Relacorilant and Pembrolizumab Extend Survival in Platinum-Resistant Ovarian Cancer

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

First Pivotal Trial Finds Cooled-Laser Prostate Therapy Effective at 3 Months With Low Morbidity

First NHS Patient Completes Next‑Generation CAR‑T Therapy for Aggressive Leukaemia

Never miss stories about

Patient Outcomes